Hepatitis C and immune globulin. 1995

J López-Jiménez, and J Odriozola, and J Pérez-Oteyza, and J García-Laraña

UI MeSH Term Description Entries
D004340 Drug Contamination The presence of organisms, or any foreign material that makes a drug preparation impure. Drug Adulteration,Drug Contamination, Chemical,Drug Contamination, Microbial,Drug Contamination, Physical,Drug Impurity,Adulteration, Drug,Chemical Drug Contamination,Chemical Drug Contaminations,Contamination, Chemical Drug,Contamination, Drug,Contamination, Microbial Drug,Contamination, Physical Drug,Contaminations, Chemical Drug,Contaminations, Microbial Drug,Contaminations, Physical Drug,Drug Adulterations,Drug Contaminations,Drug Contaminations, Chemical,Drug Contaminations, Microbial,Drug Contaminations, Physical,Drug Impurities,Impurity, Drug,Microbial Drug Contamination,Microbial Drug Contaminations,Physical Drug Contamination,Physical Drug Contaminations
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016026 Bone Marrow Transplantation The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION. Bone Marrow Cell Transplantation,Grafting, Bone Marrow,Transplantation, Bone Marrow,Transplantation, Bone Marrow Cell,Bone Marrow Grafting
D016756 Immunoglobulins, Intravenous Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA. Antibodies, Intravenous,Human Intravenous Immunoglobulin,IV Immunoglobulin,IVIG,Intravenous Antibodies,Intravenous Immunoglobulin,Intravenous Immunoglobulins,Alphaglobin,Endobulin,Flebogamma DIF,Gamimmune,Gamimmune N,Gamimune,Gamimune N,Gammagard,Gammonativ,Gamunex,Globulin-N,IV Immunoglobulins,Immune Globulin Intravenous (Human),Immune Globulin, Intravenous,Immunoglobulins, Intravenous, Human,Intraglobin,Intraglobin F,Intravenous IG,Intravenous Immunoglobulins, Human,Iveegam,Modified Immune Globulin (Anti-Echovirus Antibody),Privigen,Sandoglobulin,Venimmune,Venoglobulin,Venoglobulin-I,Globulin N,Human Intravenous Immunoglobulins,Immunoglobulin, Human Intravenous,Immunoglobulin, IV,Immunoglobulin, Intravenous,Immunoglobulins, Human Intravenous,Immunoglobulins, IV,Intravenous Immune Globulin,Intravenous Immunoglobulin, Human,Venoglobulin I

Related Publications

J López-Jiménez, and J Odriozola, and J Pérez-Oteyza, and J García-Laraña
May 1995, The New England journal of medicine,
J López-Jiménez, and J Odriozola, and J Pérez-Oteyza, and J García-Laraña
May 1995, The New England journal of medicine,
J López-Jiménez, and J Odriozola, and J Pérez-Oteyza, and J García-Laraña
February 1997, JAMA,
J López-Jiménez, and J Odriozola, and J Pérez-Oteyza, and J García-Laraña
February 1997, JAMA,
J López-Jiménez, and J Odriozola, and J Pérez-Oteyza, and J García-Laraña
August 1980, The New England journal of medicine,
J López-Jiménez, and J Odriozola, and J Pérez-Oteyza, and J García-Laraña
September 1997, Transfusion,
J López-Jiménez, and J Odriozola, and J Pérez-Oteyza, and J García-Laraña
November 1978, The New England journal of medicine,
J López-Jiménez, and J Odriozola, and J Pérez-Oteyza, and J García-Laraña
June 2007, Drugs of today (Barcelona, Spain : 1998),
J López-Jiménez, and J Odriozola, and J Pérez-Oteyza, and J García-Laraña
August 2004, Nihon rinsho. Japanese journal of clinical medicine,
J López-Jiménez, and J Odriozola, and J Pérez-Oteyza, and J García-Laraña
October 1995, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!